$BFLY

Carlson Megan sold $101K of BFLY

Carlson Megan (CAO and SVP, Finance) sold 13,804 shares of Butterfly Network, Inc. (BFLY) at $7.30 ($0.10M total) on 2026-09-04.

Original reporting
SEC EDGAR · Carlson Megan
Published Sep 9, 2026, 8:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BFLY
Neutral
medium confidence
Mentioned
$BFLY
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BFLYNeutralLow
01

Why it matters

The transaction represents a modest reduction in insider stake with limited price effect.

02

Market read

Primary insider sale; low trading relevance but useful for monitoring insider activity.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-09

Background

Form 4 filing by CAO Megan Carlson reporting an open-market sale of BFLY shares.

Company-level read

Ticker impact

$BFLYNeutralMedium confidence
Context

Insider officer sold 13,804 shares for $100,796, reducing holdings to 412,085 shares.

Expected impact

Potential modest short-term downside pressure.

Evidence & confidence

Sale size is small relative to float and typical insider transactions; no broader catalyst.

Market effects

No significant sector impact; isolated insider transaction.

Limited to U.S. market participants tracking BFLY.

Minimal global relevance.

Counterpoint

The sale could be a routine portfolio rebalancing, not a negative signal.

Key entities

  • Butterfly Network, Inc.

    Medical imaging device maker listed on Nasdaq (BFLY).

  • Megan Carlson

    Chief Administrative Officer and Senior Vice President, Finance.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QSIMed

2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.

$BFLYHigh

Why is Butterfly Network stock climbing today?

Butterfly Network (BFLY) stock rose 1.6% pre-market after Canaccord Genuity initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and AI capabilities. Analysts highlight new products and partnerships. The stock has seen positive analyst activity, with a consensus target of $11.40. Q3 earnings are due October 29.

$BFLYHigh

Evercore ISI initiates Butterfly Network stock with outperform rating

Evercore ISI initiated coverage on Butterfly Network (NYSE: BFLY) with an outperform rating and $15.00 price target, citing its ultrasound-on-chip technology and growth potential. The firm projects $550M+ revenue by 2030 and positive EBITDA by 2028. BFLY stock has risen 367% over the past year, trading at $9.15 with a $2.44B market cap. Q2 2026 results showed a smaller loss than expected but lower revenue. Needham also initiated coverage with a buy rating and $10.00 target.

$BFLYHighAI 8/10

Why is Butterfly Network stock surging today?

Butterfly Network (BFLY) stock rose 11.5% after Needham initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and Embedded business model. TD Cowen also has a Buy rating and $10 target. BFLY's Q3 revenue grew 39% YoY, with Embedded segment growth and expanding margins. The broader market had minimal impact on BFLY's surge.

$BFLYMed

Butterfly Network at Morgan Stanley conference: platform push widens reach

Butterfly Network (BFLY) presented its strategy at Morgan Stanley's conference, shifting from handheld ultrasound to a semiconductor imaging platform. The company reported 20% revenue growth, with $112M in last 12-month revenue, and highlighted partnerships like Midjourney. It aims to expand its addressable market to $250B through its Butterfly Embedded model. The company expects a fourth-generation chip in 2027 to improve image quality and challenge competitors. Management emphasized its strong